These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19007504)

  • 21. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
    Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Pope HG; Herning R; Cadet JL; Huestis MA
    Addiction; 2009 Dec; 104(12):2041-8. PubMed ID: 19804462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.
    Gustafson RA; Kim I; Stout PR; Klette KL; George MP; Moolchan ET; Levine B; Huestis MA
    J Anal Toxicol; 2004 Apr; 28(3):160-7. PubMed ID: 15107145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
    Fraser AD; Worth D
    Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papain: a novel urine adulterant.
    Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
    J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid concentrations in hair from documented cannabis users.
    Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
    Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
    Huestis MA; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
    Niedbala RS; Kardos KW; Fritch DF; Kardos S; Fries T; Waga J; Robb J; Cone EJ
    J Anal Toxicol; 2001; 25(5):289-303. PubMed ID: 11499881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary clearance of 11-nor-9-carboxy-Δ
    Sempio C; Huestis MA; Kaplan B; Klawitter J; Christians U; Henthorn TK
    Drug Test Anal; 2022 Aug; 14(8):1368-1376. PubMed ID: 35332698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples.
    Skopp G; Pötsch L
    J Anal Toxicol; 2004; 28(1):35-40. PubMed ID: 14987422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
    ElSohly MA; deWit H; Wachtel SR; Feng S; Murphy TP
    J Anal Toxicol; 2001 Oct; 25(7):565-71. PubMed ID: 11599601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the impact of hemp food consumption on workplace drug tests.
    Leson G; Pless P; Grotenhermen F; Kalant H; ElSohly MA
    J Anal Toxicol; 2001; 25(8):691-8. PubMed ID: 11765026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid quantification of urinary 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid using fast gas chromatography-mass spectrometry.
    Jamerson MH; Welton RM; Morris-Kukoski CL; Klette KL
    J Anal Toxicol; 2005 Oct; 29(7):664-8. PubMed ID: 16419397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Jamerson MH; McCue JJ; Klette KL
    J Anal Toxicol; 2005 Oct; 29(7):627-31. PubMed ID: 16419391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marijuana-positive urine test results from consumption of hemp seeds in food products.
    Fortner N; Fogerson R; Lindman D; Iversen T; Armbruster D
    J Anal Toxicol; 1997 Oct; 21(6):476-81. PubMed ID: 9323528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and quantitation of 11-nor-delta9-tetrahydrocannabivarin-9-carboxylic acid, a major metabolite of delta9-tetrahydrocannabivarin.
    ElSohly MA; Feng S; Murphy TP; Warrington AW; Ross S; Nimrod A; Mehmedic Z; Fortner N
    J Anal Toxicol; 2001 Sep; 25(6):476-80. PubMed ID: 11550824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.